Skip to main content

Table 1 Patient and disease characteristics of the ITT population (n = 26)

From: A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

Age (years)

Median

58

  
 

Range

34–78

  
 

Patients

 

ECOG performance status

   

 0

  

15

58%

 1

  

10

38%

 2

  

1

4%

Primary site:

    

 Ovarian

  

22

85%

 Fallopian tube

  

1

4%

 Peritoneum

  

3

11%

Histology

    

 Serous

  

22

85%

 Endometrioid

  

1

4%

 Endometrioid and clear cell

  

1

4%

 Other

  

2

7%

Differentiation

    

 Grade 1

  

-

 

 Grade 2

  

1

4%

 Grade 3

  

24

92%

 Grade not assigned

  

1

4%

Tumor expression of mucin 1 by immunohistochemistry

 Positive

  

23

88%

 Negative

  

2

8%

 Not assessed

  

1

4%